Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study will evaluate the safety and efficacy of Tesomet (tesofensine + metoprolol) in subjects 18 years of age or older, with HO
Epistemonikos ID: a49cf6df054407d87abaa8064506642141999a2d
First added on: May 09, 2024